Category :

Polyplastics Launches New Eco-friendly PLASTRON (R) ︎LFT with Reduced Weight, Higher Rigidity, and Strong Damping

TOKYO,Feb. 13,2025-- Polyplastics Co.,Ltd.,a global leader in engineering plastics,has launched PLASTRON (R) LFT (long fiber-reinforced thermoplastic) RA627P,an eco-friendly composite of polypropylene

EnergyFeb 14, 2025

DAAN Biotherapeutics Signs Antibody Exclusive Licensing Agreement with LigaChem Biosciences for ADC (Antibody-Drug Conjugate) Therapeutic Development

SEOUL,South Korea,Feb. 13,2025-- DAAN Biotherapeutics,a leading innovative drug development company specializing in T-cell receptor (TCR)- based therapies,has signed an exclusive licensing agreement w

Chip TechFeb 14, 2025

Aker Horizons ASA: Fourth-quarter results 2024

FORNEBU,Norway,Feb. 13,2025-- Aker Horizons ASA (OSE:AKH),a developer of green energy and industry,today announced results for the fourth quarter 2024. Aker Horizons\' net capital employed stood at NO

SoftwareFeb 14, 2025

Cloud4C Secures Dual AI Specializations on Microsoft Azure, Strengthening AI Capabilities

SINGAPORE,Feb. 13,2025-- Cloud4C,a global leader in AI-driven cloud and cybersecurity services,has achieved two prestigious AI specializations on Microsoft Azure: \'AI Platform on Microsoft Azure\' an

SpaceFeb 14, 2025

Fujitsu to offer Fujitsu Cloud Service Generative AI Platform for secure and flexible enterprise data management

KAWASAKI,Japan,Feb. 13,2025-- Fujitsu today announced the launch of theFujitsu Cloud Service Generative AI Platform. The new service,which combines data confidentiality with the ease of use of the clo

AIFeb 14, 2025

Happy Chinese New Year 2025: Jiangsu's Intangible Cultural Heritage Takes the Global Spotlight

NANJING,China,Feb. 13,2025-- On December 4th,2024,UNESCO inscribed the "Spring Festival,Social Practices of the Chinese People in Celebration of Traditional New Year" on its Representative L

SpaceFeb 14, 2025

Restore Vision Announces First Patient Dosed in Phase I/II Clinical Trial of RV-001 for Gene-Agnostic Retinitis Pigmentosa

The first optogenetic "Chimeric Rhodopsin" gene therapy tested in humans. RV-001 starting dose was generally well tolerated in this open-label trial.

Big DataFeb 14, 2025

CRIMSONLOGIC AND BDO SINGAPORE SIGN STRATEGIC PARTNERSHIP TO DEVELOP SPECIALIZED GENERATIVE AI ADVISORY PLATFORM

This strategic partnership aims to transform professional advisory services by leveraging cutting-edge Generative AI to provide accurate,domain-specific insights

TechFeb 14, 2025

Webull Masters 2025 Kicks Off: an Exciting Stock Trading Competition in Thailand with Over THB170,000 in Prizes

BANGKOK,Feb. 13,2025-- Webull Securities (Thailand) Co. Ltd. ("Webull Thailand"),the Thai subsidiary of Webull Corporation ("Webull"),a leading global digital investment platform,

AIFeb 14, 2025

Schwab Makes Expanded 24-Hour Trading Available to All Clients

Overnight trading of all S&P 500®,Nasdaq-100® stocks and hundreds of ETFs is now available to all Schwab clients via the thinkorswim® platform suite

Big DataFeb 14, 2025
1 ... 327 328 329 330 331 332 333 ... 1346
Your premier source for cutting-edge news in the realms of technology, artificial intelligence, energy, and more. Explore the future of tech with Arinstar! Stay informed, stay inspired!

Quick Search

Explore our curated content, stay informed about groundbreaking innovations, and journey into the future of science and tech.

© ArinstarTechnology

Privacy Policy